Work

A Case of Autoimmune Pulmonary Alveolar Proteinosis

Year: 2026

Type: article

Abstract: Chemotherapeutic agents or regular doses of Rituximab may represent a potential therapeutic option for refractory cases of autoimmune pulmonary alveolar proteinosis.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.72040

Authors: Meher Binte Ali, Danish Jilani, Syeda Hafsa Qadri, Yilin Song, Nancy Hardy

Institutions: University of Maryland Medical Center, Dow University of Health Sciences

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820

OpenAlex ID: W7130393893

FWCI:

Cites: 15

Cited by:

Related to: